Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

NCT00088673 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

950

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: 3APS

Sponsor

Bellus Health Inc. - a GSK company